Jalaja Potluri
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 54
- Chronic Myeloid Leukemia Treatments 24
- Multiple Myeloma Research and Treatments 13
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 27
- Myeloproliferative Neoplasms: Diagnosis and Treatment 17
- Oncology top 5%
- Neutropenia and Cancer Infections 11
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 11
-
- Acute Lymphoblastic Leukemia research 11
- Co-authors
- Brenda ChylaCourtney D. DiNardoKeith W. PratzMarina KonoplevaDaniel A. PollyeaBrian A. JonasHagop M. KantarjianAndrew H. Wei
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Jalaja Potluri
74 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Hematology 2.7k
- Genetics 1.4k
- Pathology and Forensic Medicine 606
- Oncology 654
- Molecular Biology 1.6k
Countries citing papers authored by Jalaja Potluri
This map shows the geographic impact of Jalaja Potluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jalaja Potluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jalaja Potluri more than expected).
Fields of papers citing papers by Jalaja Potluri
This network shows the impact of papers produced by Jalaja Potluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jalaja Potluri. The network helps show where Jalaja Potluri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jalaja Potluri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 59 | |
| 8 | 2022 | 75 | |
| 9 | 2022 | 30 | |
| 10 | 2022 | 10 | |
| 11 | 2020 | 27 | |
| 12 | 2019 | 28 | |
| 13 | 2019 | 29 | |
| 14 | 2018 | 113 | |
| 15 | Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b studybreakdown → | 2018 | 498 |
| 16 | 2017 | 3 | |
| 17 | 2017 | 12 | |
| 18 | 2017 | 167 | |
| 19 | 2014 | 50 | |
| 20 | Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. | 1996 | 71 |
About Jalaja Potluri
Jalaja Potluri is a scholar working on Hematology, Genetics and Oncology, having authored 79 papers that have together received 3.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (54 papers), Chronic Lymphocytic Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (24 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Multiple Myeloma Research and Treatments (13 papers), Neutropenia and Cancer Infections (11 papers), Acute Lymphoblastic Leukemia research (11 papers) and Histone Deacetylase Inhibitors Research (11 papers). The work is most often cited by research in Hematology (2.7k citations), Genetics (1.4k citations) and Pathology and Forensic Medicine (606 citations). Jalaja Potluri has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Brenda Chyla, Courtney D. DiNardo, Keith W. Pratz, Marina Konopleva, Daniel A. Pollyea, Brian A. Jonas, Hagop M. Kantarjian, Andrew H. Wei, Anthony Letai and Martha Arellano. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.